Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,941 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Prognostic implications of alpha-fetoprotein and C-reactive protein elevation in hepatocellular carcinoma following resection (PACE): a large cohort study of 2770 patients.
Lin KY, Chen QJ, Tang SC, Lin ZW, Zhang JX, Zheng SM, Li YT, Wang XM, Lu Q, Fu J, Guo LB, Zheng LF, You PH, Wu MM, Lin KC, Zhou WP, Yang T, Zeng YY. Lin KY, et al. Among authors: zhang jx. BMC Cancer. 2023 Dec 5;23(1):1190. doi: 10.1186/s12885-023-11693-6. BMC Cancer. 2023. PMID: 38053048 Free PMC article.
Perioperative safety, oncologic outcome, and risk factors of salvage liver resection for initially unresectable hepatocellular carcinoma converted by transarterial chemoembolization plus tyrosine kinase inhibitor and anti-PD-1 antibody: a retrospective multicenter study of 83 patients.
Lin KY, Lin ZW, Chen QJ, Luo LP, Zhang JX, Chen JH, Wang K, Tai S, Zhang ZB, Wang SF, Zhang JY, You WY, Wang B, You PH, Lin KC, Yang T, Zeng YY. Lin KY, et al. Among authors: zhang zb, zhang jx, zhang jy. Hepatol Int. 2023 Dec;17(6):1477-1489. doi: 10.1007/s12072-023-10561-6. Epub 2023 Jun 29. Hepatol Int. 2023. PMID: 37382760
Association of hepatitis B virus DNA levels with efficacy and safety outcomes in patients with hepatitis B virus-associated advanced hepatocellular carcinoma receiving tyrosine kinase inhibitor plus anti-PD-1 antibody: a multicenter propensity-matched study.
Chen QJ, Lin KY, Lin ZW, Zhang B, Liu MQ, Zhang JX, Huang QZ, Lin KC, Zhang JY, Wei FQ, You PH, You S, Jiang YB, Zhang H, Cheng ZQ, Wang CR, Zeng YY. Chen QJ, et al. Among authors: zhang b, zhang jx, zhang jy, zhang h. Int Immunopharmacol. 2023 Dec;125(Pt A):111098. doi: 10.1016/j.intimp.2023.111098. Epub 2023 Nov 3. Int Immunopharmacol. 2023. PMID: 37925946
1,941 results